Host: Lee Freedman, MD

Guest: Emile Mohler III, MD

How should we approach vulnerable plaques in the coronaries and how can we calculate more precise risk levels in both high- and average-risk patients? Host Dr. Lee Freedman addresses diagnosis and treatment options with Dr. Emile Mohler III, associate professor of medicine and director of vascular medicine within the University of Pennsylvania Health System.

Dr. Mohler passed away in October 2017. This interview honors his commitment and dedication to medicine.

Host: Lee Freedman, MD

Guest: Emile Mohler III, MD

A ruptured vascular plaque with subsequent thrombus often triggers the heart attack that occurs without warning. How do we identify and treat at-risk cardiac patients? Host Dr. Lee Freedman discusses an array of tools to evaluate plaque burden and promote plaque stabilization with Dr. Emile Mohler III, associate professor of medicine and director of vascular medicine within the University of Pennsylvania Health System.

Dr. Mohler passed away in October 2017. This interview honors his commitment and dedication to medicine.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Ann K. Wittkowsky, PharmD, CACP, FASHP, FCCP

Dr. Charles Turck is joined by guest Dr. Ann Wittkowsky, director of anticoagulation services at the University of Washington Medical Center and co-author of "Genetic Testing for Warfarin Dosing: Not Yet Ready for Primetime" appearing in the Journal Pharmacotherapy. Dr. Wittkowsky overviews some clinical pearls associated with anticoagulation therapy, and the challenges clinicians face delivering this care.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Ann K. Wittkowsky, PharmD, CACP, FASHP, FCCP

There are many well-established correlations between warfarin dosing and therapeutic endpoints. One realm we’re still working to conquer includes the influence of genetics on the application of warfarin and other medicines. Ann Wittkowsky, PharmD, director of anticoagulation services at the University of Washington Medical Center in Seattle, joins host Dr. Charles Turck to examine the potential impact of genetics in pharmacotherapeutics.

Host: Gary Kohn, MD

Guest: Suzanne Cannegieter

Dr. Suzanne Cannegieter, Director of Clinical Epidemiology at Leiden University in the Netherlands, discusses her team's work with the international Wright Project focusing on connections between air travel and venous thrombosis.

Host: Gary Kohn, MD

Guest: Suzanne Cannegieter

Dr. Suzanne Cannegieter, director of clinical epidemiology, and the lead international researcher for the Wright Project, from Leiden University Medical Center in the Netherlands, talks about the history of research on deep venous thrombosis and extensive air travel.

Host: Susan Dolan, RN, JD

Guest: Jeanette Reschke, RN

An estimated one billion venipunctures are performed annually and they are commonly viewed as one of the most painful invasive procedures performed. It takes an average of 2.4 sticks in order to obtain successful catheter placement. Is there a better way? Join Registered Nurse Jenny Reschke discuss the Vein Viewer.

Host: Cathleen Margolin, PhD

Guest: Abbas Chamsuddin, MD

Dr. Abbas Chamsuddin of the Emory School of medicine discusses the latest techniques for treating varicose veins.

Host: Larry Kaskel, MD

Guest: Elizabeth Tieman, MD

Work-life balance: how many of us can say we have it, let alone come close to having it? Board-certified radiologist Dr. Betsy Tieman is one healthcare professional who can say she achieved work-life balance by leaving private practice where she was working 14 hours a day to take advantage of locum tenens work, which also enabled her to train and compete in triathlons.

Host: Paul Raeburn

Guest: Tim Westmoreland, PhD

What's good about the Federal/State Medicaid program, and how could it be improved? Tim Westmoreland, a lawyer and health care expert at the Georgetown University Health Law Institute in DC, discusses the problem of getting more people covered.